MB/PE  Maxim Group


     Office Locations:

405 Lexington Ave
New York, NY 10174
Phone: 212-895-3500
Fax: 212-895-3555

Get all office locations for this firm with a National Database subscription or New York Database subscription.


  • Growth
  • Middle Market



  • Life Sciences & Healthcare



    Founded in 2002, Maxim Group is a leading full-service investment banking, securities and wealth management firm headquartered in New York. Since 2009, the Maxim Merchant Capital Division has closed more than $414,000,000 in traditional private and public financings. Within the biotech sector, Maxim looks for companies that address significant unmet needs and have a clear regulatory path.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Alex Forschner Senior Managing Director
    Christopher Brothers Executive Managing Director


    Portfolio companies include:

        web link

        web link

      ContraFect Corporation
        web link

      Diffusion Pharmaceuticals
        web link

      Edge Therapeutics
        web link

        web link

      root9B Technologies
        web link

      X4 Pharmaceuticals
        web link


    Recent News: